Summary
| Direction in Alzheimer's Disease and Other Dementias | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Neurological |
| Compared against | AD vs healthy/non-AD (core CSF/plasma biomarker) |
| Source | Abukuri et al. 2024 — doi:10.1155/2024/6668159 |
| Condition atlas | Alzheimer's Disease and Other Dementias Biomarker Atlas |
Related Neurological markers in Alzheimer's Disease and Other Dementias
Full list: Alzheimer's Disease and Other Dementias Biomarker Atlas.
Frequently asked questions
Is Phosphorylated Tau (p-tau181) high or low in Alzheimer's Disease and Other Dementias?
Elevated. Studies summarised in the OSMF atlas report higher Phosphorylated Tau (p-tau181) in Alzheimer's Disease and Other Dementias than in the reference group of the cited comparison (AD vs healthy/non-AD (core CSF/plasma biomarker)). Source: Abukuri et al. 2024.
Which test measures Phosphorylated Tau (p-tau181)?
The atlas record does not list a standardised clinical test code (LOINC) for Phosphorylated Tau (p-tau181), which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.
Is one abnormal Phosphorylated Tau (p-tau181) result diagnostic of Alzheimer's Disease and Other Dementias?
No. No single biomarker is diagnostic of Alzheimer's Disease and Other Dementias. Phosphorylated Tau (p-tau181) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Subscribe on Substack
Last reviewed: 2026-07-03 · Page generated from alzheimer-s-disease-and-other-dementias.json · Browse: Alzheimer's Disease and Other Dementias atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.